4DMedical Limited (4DX.AX)
AUD 0.46
(1.11%)
AUD 0.46
(1.11%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | -25.48 Million AUD | 60.45% |
| 2023 | -64.43 Million AUD | -43.59% |
| 2022 | -44.87 Million AUD | 43.33% |
| 2021 | -79.19 Million AUD | -1082.66% |
| 2020 | 8.05 Million AUD | 9556.06% |
| 2019 | -85.22 Thousand AUD | 87.14% |
| 2018 | -662.69 Thousand AUD | 42.55% |
| 2017 | -1.15 Million AUD | -971.93% |
| 2016 | -107.62 Thousand AUD | 34.73% |
| 2015 | -164.89 Thousand AUD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q4 | -25.48 Million AUD | 16.73% |
| 2024 Q1 | -43.97 Million AUD | 31.76% |
| 2024 Q2 | -28.64 Million AUD | 34.86% |
| 2024 Q3 | -30.6 Million AUD | -6.85% |
| 2024 FY | -25.48 Million AUD | 60.45% |
| 2023 Q3 | -65.37 Million AUD | -63.27% |
| 2023 FY | -64.43 Million AUD | -43.59% |
| 2023 Q4 | -64.43 Million AUD | 1.43% |
| 2023 Q2 | -40.03 Million AUD | 2.8% |
| 2023 Q1 | -41.18 Million AUD | 8.21% |
| 2022 Q1 | -59.51 Million AUD | 24.84% |
| 2022 FY | -44.87 Million AUD | 43.33% |
| 2022 Q4 | -44.87 Million AUD | 2.39% |
| 2022 Q3 | -45.97 Million AUD | 21.93% |
| 2022 Q2 | -58.89 Million AUD | 1.05% |
| 2021 FY | -79.19 Million AUD | -1082.66% |
| 2021 Q2 | -42.25 Million AUD | 0.87% |
| 2021 Q1 | -42.62 Million AUD | -628.96% |
| 2021 Q3 | -79.91 Million AUD | -89.11% |
| 2021 Q4 | -79.19 Million AUD | 0.91% |
| 2020 Q4 | 8.05 Million AUD | -12.85% |
| 2020 Q1 | 1.57 Million AUD | 1943.06% |
| 2020 FY | 8.05 Million AUD | 9556.06% |
| 2020 Q2 | 1.39 Million AUD | -11.21% |
| 2020 Q3 | 9.24 Million AUD | 563.0% |
| 2019 FY | -85.22 Thousand AUD | 87.14% |
| 2019 Q4 | -85.22 Thousand AUD | 0.0% |
| 2019 Q3 | -85.22 Thousand AUD | 0.0% |
| 2019 Q1 | 1.66 Million AUD | 0.0% |
| 2018 FY | -662.69 Thousand AUD | 42.55% |
| 2017 FY | -1.15 Million AUD | -971.93% |
| 2016 FY | -107.62 Thousand AUD | 34.73% |
| 2015 FY | -164.89 Thousand AUD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Adherium Limited | -6.1 Million AUD | -317.499% |
| Aroa Biosurgery Limited | -3.74 Million AUD | -580.132% |
| Atomo Diagnostics Limited | -3.6 Million AUD | -607.279% |
| Anteris Technologies Ltd | -28.49 Million AUD | 10.574% |
| Control Bionics Limited | -19.02 Thousand AUD | -133879.266% |
| CardieX Limited | 2.74 Million AUD | 1027.988% |
| Compumedics Limited | 5.08 Million AUD | 600.993% |
| Cochlear Limited | -269.9 Million AUD | 90.557% |
| CleanSpace Holdings Limited | 698.59 Thousand AUD | 3748.129% |
| Cyclopharm Limited | -7.49 Million AUD | -239.847% |
| EMVision Medical Devices Ltd | -15.7 Million AUD | -62.316% |
| Nova Eye Medical Limited | -2.8 Million AUD | -809.548% |
| HeraMED Limited | -799.34 Thousand AUD | -3088.29% |
| Imricor Medical Systems, Inc. | 14.48 Million AUD | 275.97% |
| ImpediMed Limited | -23.48 Million AUD | -8.5% |
| InhaleRx Limited | -155.54 Thousand AUD | -16284.776% |
| LBT Innovations Limited | -604 Thousand AUD | -4119.46% |
| Micro-X Limited | 826.99 Thousand AUD | 3181.689% |
| Neurotech International Limited | -2.11 Million AUD | -1107.571% |
| OncoSil Medical Limited | -4.43 Million AUD | -475.2% |
| PolyNovo Limited | -30.52 Million AUD | 16.515% |
| Respiri Limited | 413.68 Thousand AUD | 6260.554% |
| SomnoMed Limited | -15.16 Million AUD | -68.079% |
| Universal Biosensors, Inc. | -5.3 Million AUD | -380.502% |
| Uscom Limited | -1.53 Million AUD | -1565.032% |
| Visioneering Technologies, Inc. | -4.08 Million AUD | -524.194% |